900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
3p partial monosomy syndrome (disorder)	Preferred (foundation metadata concept)
3p partial trisomy syndrome	Preferred (foundation metadata concept)
3p partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
3p syndrome	Acceptable (foundation metadata concept)
3p25.3 deletion syndrome	Preferred (foundation metadata concept)
3p25.3 deletion syndrome (disorder)	Preferred (foundation metadata concept)
3p25.3 microdeletion syndrome	Acceptable (foundation metadata concept)
3p25.3 microdeletion syndrome is a rare chromosomal anomaly characterized by intellectual disability, epilepsy or EEG abnormalities, poor speech, ataxia, and stereotypic hand movements.	Preferred (foundation metadata concept)
3q partial trisomy syndrome	Preferred (foundation metadata concept)
3q partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
3q subtelomere deletion syndrome	Acceptable (foundation metadata concept)
3q13 microdeletion syndrome	Preferred (foundation metadata concept)
3q13 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
3q13 microdeletion syndrome is a rare chromosomal anomaly syndrome resulting from a partial deletion of the long arm of chromosome 3. Phenotype can be highly variable, but it is primarily characterized by significant developmental delay, postnatal growth above the mean, muscular hypotonia and distinctive facial features (such as broad and prominent forehead, hypertelorism, epicanthic folds, ptosis, short philtrum, protruding lips with a full lower lip, high arched palate). Abnormal hypoplastic male genitalia and skeletal abnormalities are frequently present.	Preferred (foundation metadata concept)
3q23 microdeletion syndrome	Acceptable (foundation metadata concept)
3q26 microduplication syndrome	Preferred (foundation metadata concept)
3q26 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
3q26q27 microdeletion syndrome	Preferred (foundation metadata concept)
3q26q27 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
3q27.3 microdeletion syndrome	Preferred (foundation metadata concept)
3q27.3 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
3q27.3 microdeletion syndrome is a rare chromosomal anomaly syndrome, resulting from the partial deletion of the long arm of chromosome 3, characterized by mild to severe intellectual disability, neuropsychiatric disorders of the psychotic and dysthymic spectrum, mild distinctive facial dysmorphism (including slender face, deep-set eyes, high nasal bridge with a hooked nose, small, low- set ears, short philtrum, small mouth with thin upper lip, prognathism) and a marfanoid habitus.	Preferred (foundation metadata concept)
3q29 microdeletion syndrome	Preferred (foundation metadata concept)
3q29 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
3q29 microduplication	Preferred (foundation metadata concept)
3q29 microduplications are recently described chromosomal abnormalities with unclear clinical significance.	Preferred (foundation metadata concept)
3rd	Acceptable (foundation metadata concept)
3rd HiB and DTP vaccine given	Preferred (foundation metadata concept)
3rd HiB and DTP vaccine given (situation)	Preferred (foundation metadata concept)
3rd Hib and DTP vaccine given	Preferred (foundation metadata concept)
3rd Japanese encephalitis vaccination	Preferred (foundation metadata concept)
3rd Japanese encephalitis vaccination	Preferred (foundation metadata concept)
3rd Japanese encephalitis vaccination (procedure)	Preferred (foundation metadata concept)
3rd Japanese encephalitis vaccination (procedure)	Preferred (foundation metadata concept)
3rd floor	Acceptable (foundation metadata concept)
3rd hepatitis A junior vaccination	Acceptable (foundation metadata concept)
3rd left lumbar vein	Acceptable (foundation metadata concept)
3rd nerve palsy	Acceptable (foundation metadata concept)
3rd nerve palsy	Acceptable (foundation metadata concept)
3rd right lumbar vein	Acceptable (foundation metadata concept)
3rd specimen	Acceptable (foundation metadata concept)
3rd trimester	Acceptable (foundation metadata concept)
3x /day	Acceptable (foundation metadata concept)
4	Preferred (foundation metadata concept)
4	Preferred (foundation metadata concept)
4 (AJCC)	Acceptable (foundation metadata concept)
4 (UICC)	Acceptable (foundation metadata concept)
4 (qualifier value)	Preferred (foundation metadata concept)
4 Buck shot	Preferred (foundation metadata concept)
4 Buck shot, device	Acceptable (foundation metadata concept)
4 Buck shot, device (qualifier value)	Preferred (foundation metadata concept)
4 French gauge	Preferred (foundation metadata concept)
4 French gauge (qualifier value)	Preferred (foundation metadata concept)
4 MUGS	Acceptable (foundation metadata concept)
4 PD base out prism test	Acceptable (foundation metadata concept)
4 WAY FOGGER	Preferred (foundation metadata concept)
4 WAY FOGGER (product)	Preferred (foundation metadata concept)
4 diopter prism test	Preferred (foundation metadata concept)
4 diopter prism test (procedure)	Preferred (foundation metadata concept)
4 hours	Preferred (foundation metadata concept)
4 hours (qualifier value)	Preferred (foundation metadata concept)
4 hours post-dose	Preferred (foundation metadata concept)
4 hours post-dose (qualifier value)	Preferred (foundation metadata concept)
4 level of presenting part in relation to ischial spines	Preferred (foundation metadata concept)
4 level of presenting part in relation to ischial spines (finding)	Preferred (foundation metadata concept)
4 millimole potassium exchanges/day	Preferred (foundation metadata concept)
4 millimole potassium exchanges/day (qualifier value)	Preferred (foundation metadata concept)
4 millimole potassium exchanges/kg body weight	Preferred (foundation metadata concept)
4 millimole potassium exchanges/kg body weight (qualifier value)	Preferred (foundation metadata concept)
4 millimole potassium exchanges/meal	Preferred (foundation metadata concept)
4 millimole potassium exchanges/meal (qualifier value)	Preferred (foundation metadata concept)
4 o'clock position	Preferred (foundation metadata concept)
4 o'clock position (qualifier value)	Preferred (foundation metadata concept)
4 o'clock position on mammogram	Preferred (foundation metadata concept)
4 o'clock position on mammogram (finding)	Preferred (foundation metadata concept)
4 part fracture	Preferred (foundation metadata concept)
4 part fracture (morphologic abnormality)	Preferred (foundation metadata concept)
4 pin head fixation device	Preferred (foundation metadata concept)
4 pin head fixation device (physical object)	Preferred (foundation metadata concept)
4 point gait	Preferred (foundation metadata concept)
4 point gait (finding)	Preferred (foundation metadata concept)
4 serotype	Preferred (foundation metadata concept)
4 serotype (qualifier value)	Preferred (foundation metadata concept)
4 serotypes	Acceptable (foundation metadata concept)
4 times a week	Acceptable (foundation metadata concept)
4 to 6 times a day	Acceptable (foundation metadata concept)
4'-hydroxybupivacaine	Preferred (foundation metadata concept)
4'-hydroxybupivacaine (substance)	Preferred (foundation metadata concept)
4+ pitting edema	Preferred (foundation metadata concept)
4+ pitting edema (finding)	Preferred (foundation metadata concept)
4,4'-dihydroxybiphenyl	Preferred (foundation metadata concept)
4,4'-dihydroxybiphenyl (substance)	Preferred (foundation metadata concept)
4,4'-dihydroxybiphenyl only product	Preferred (foundation metadata concept)
4,4'-dihydroxybiphenyl-containing product	Preferred (foundation metadata concept)
4,4'-methylene-bis-(2-chloroaniline)	Preferred (foundation metadata concept)
4,4'-methylene-bis-(2-chloroaniline) (substance)	Preferred (foundation metadata concept)
4,4'-methylenebisphenol	Acceptable (foundation metadata concept)
4,4'-methylenediphenol	Acceptable (foundation metadata concept)
4,4'-oxydi-2-butanol	Preferred (foundation metadata concept)
4,4'-oxydi-2-butanol (substance)	Preferred (foundation metadata concept)
4,5-Dihydroxyhexanolactone	Preferred (foundation metadata concept)

Start Previous Page 113 of 13176 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)